F. Jotereau, M. C. Pandolfino, and D. Boudart, High-fold expansion of human cytotoxic T-lymphocytes specific for autologous melanoma cells for use in immunotherapy, J Immunother, vol.10, pp.405-416, 1991.

S. L. Topalian, L. M. Muul, D. Solomon, and S. A. Rosenberg, Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials, J Immunol Methods, vol.102, pp.127-168, 1987.

L. Novellino, C. Castelli, and G. Parmiani, A listing of human tumor antigens recognized by T cells March 2004 update, Cancer Immunol Immunother, vol.54, pp.187-207, 2005.

M. E. Dudley, J. R. Wunderlick, and J. C. Yang, A phase I study of non myeloablative Chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma, J Immunother, vol.25, pp.243-250, 2002.

M. E. Dudley, J. R. Wunderlich, and P. F. Robbins, Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes, Science, vol.298, p.850, 2002.

A. Mackensen, N. Meidenbauer, and S. Vogl, Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma, J Clin Oncol, vol.24, pp.5060-5069, 2006.

R. A. Morgan, M. E. Dudley, and J. R. Wunderlich, Cancer regression in patients after transfer of genetically engineered lymphocytes, Science, vol.314, pp.126-129, 2006.

V. Vignard, B. Lemercier, and A. Lim, Adoptive transfer of tumorreactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells, J Immunol, vol.175, pp.4797-805, 2005.
URL : https://hal.archives-ouvertes.fr/inserm-02482064

C. Yee, J. A. Thompson, and D. Byrd, Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma in vivo persistence migration and antitumor effect of transferred T cells, Proc Natl Acad Sci, vol.99, pp.16168-73, 2002.

H. Benlalam, N. Labarriere, and B. Linard, Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL) implications for immunotherapy, Eur J Immunol, vol.31, pp.2007-2022, 2001.
URL : https://hal.archives-ouvertes.fr/inserm-02482156

V. Lennerz, M. Fatho, and C. Gentilini, The response of autologous T cells to a human melanoma is dominated by mutated neoantigens, Proc Natl Acad Sci, vol.102, pp.16013-16021, 2005.

M. Wolfl, J. Kuball, and W. Y. Ho, Activation-induced expression of CD137 permits detection isolation and expansion of the full repertoirze of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities, Blood, vol.110, pp.201-210, 2007.

M. Burkett, K. Shafer-weaver, S. Strobl, M. Baseler, and A. Malyguine, A novel flow cytometric assay for evaluating cell-mediated cytotoxicity, J Immunother, vol.4, pp.396-402, 2005.

N. Gervois, N. Labarrière, and S. Leguiner, High avidity CTL are efficently induced from PBL upon stimulation by peptide pulsed melanoma cells, Clin Cancer Res, vol.6, pp.1469-1477, 2000.

L. Gattinoni, D. J. Powell, . Jr, S. A. Rosenberg, and N. P. Restifo, Adoptive immunotherapy for cancer building on success, Nat Rev Immunol, vol.6, pp.383-93, 2006.

B. Dreno, J. M. Nguyen, and A. Khammari, Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma, Cancer Immunol Immunother, vol.51, pp.539-585, 2002.
URL : https://hal.archives-ouvertes.fr/inserm-02482144

A. Khammari, J. M. Nguyen, and M. C. Pandolfino, Long-term follow-up of patients treated by adoptive transfer of melanoma tumorinfiltrating lymphocytes as adjuvant therapy for stage III melanoma, Cancer Immunol Immunother, vol.56, pp.1853-60, 2007.

N. Labarriere, M. C. Pandolfino, and N. Gervois, Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients, Cancer Immunol Immunother, vol.51, pp.532-540, 2002.
URL : https://hal.archives-ouvertes.fr/inserm-02482115

E. De-plaen, C. Lurquin, and B. Lethe, Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes, Methods, vol.12, pp.125-167, 1997.

H. Benlalam, V. Vignard, and A. Khammari, Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients, Cancer Immunol Immunother, vol.56, pp.515-541, 2007.

D. Valmori, J. Fonteneau, and G. Gervois, Enhanced generation of specific tumor-reactive CTL in vitro by Melan-A/MART-1 immunodominant peptide analog, J Immunol, vol.160, pp.1750-1758, 1998.

J. F. Fonteneau, L. Dréan, E. Gervois, N. Leguiner, S. Diez et al., Segregation of biological responses of melanoma-specific CTL, J Immunol, vol.159, pp.2831-2839, 1997.

N. Meidenbauer, J. Marienhagen, and M. Laumer, Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients, J Immunol, vol.170, pp.2161-2170, 2003.

J. Zhou, X. Shen, J. Huang, R. J. Hodes, S. A. Rosenberg et al., Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy, J Immunol, vol.175, pp.7046-52, 2005.

C. Germeau, W. Ma, and F. Schiavetti, High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens, J Exp Med, vol.201, pp.241-249, 2005.

C. Lurquin, B. Lethe, D. Plaen, and E. , Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen, J Exp Med, vol.201, pp.249-57, 2005.

M. Bodinier, M. A. Peyrat, and C. Tournay, Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding, Nat Med, vol.6, pp.707-717, 2000.

N. Labarriere, N. Gervois, A. Bonnin, R. Bouquié, F. Jotereau et al., PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by Melan-A/A2 multimer immunomagnetic sorting, Cancer Immunol Immunother, vol.57, pp.185-195, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00167752

E. Godefroy, A. Moreau-aubry, E. Diez, B. Dréno, F. Jotereau et al., 3-dependent cross-presentation of matrix metalloproteinase-2 by melanoma cells give rise to a new tumor antigen, J Exp Med, vol.202, pp.71-72, 2005.